Michele Buzon, professor of anthropology at Purdue University, is a bioarchaeologist who has excavated in the Nubian region of modern-day Sudan, to better understand interactions between Egyptians and Nubians.

Highly energetic, “hot” electrons have the potential to help solar panels more efficiently harvest light energy.

A Purdue University data science and machine learning innovator wants to help organizations and users get the most for their money when it comes to cloud-based databases.

An innovation turning waste material into stretchable devices may soon provide a new option for creating self-powered biomedical inventions.

New software designed to help manufacturers better predict and adjust costs may assist organizers one day with huge events such as the Olympic Games.

Purdue University researchers are developing a smartphone app that can accurately extract information about a person’s blood hemoglobin content from a photo of the inner eyelid.

A Purdue University patented method for single biomolecule detection that overcomes limitations of current technologies may help in the fight against COVID-19.

The COVID-19 pandemic has forced public health, supply chain, transportation, government, economic and many other entities to interact in real time. One of the challenges in large systems interacting in this way is that even tiny errors in one system can cause devastating effects across the entire system chain. Now, Purdue University innovators have come up with a possible solution: A set of patented algorithms that predict, identify, diagnose and prevent abnormalities in large and complex systems.

Leaf Spec Ag Technologies took first place in the Spring 2020 Demo Day, which was held virtually because of the COVID-19 pandemic. The startup’s technologies provide a digital lab solution for growers to identify in real time the nutrient and chemical compositions of plants.

The technologies were developed in the lab of Jian Jin, a Purdue assistant professor of agricultural and biological engineering.

Luna Lu is investigating unique ways to build artificial intelligence into concrete-paved bridges and highways, enabling them to prevent and repair their own damage.

Pure niclosamide (left) clouds a solution, and the crystalline structure of the drug prevents absorption. OHPP-developed niclosamide (right), created by Purdue’s Yuan Yao, is over 5,000 times more soluble. Solubility could be key to niclosamide being an effective drug against the SARS-CoV-2 virus causing the COVID-19 pandemic.

Bindley Bioscience Center in Purdue University’s Discovery Park has signed an agreement with Eyestem Research Private Limited, Bangalore, India, to develop cellular platforms for COVID-19 research.

Under the agreement, Purdue investigators will use Eyestem’s human lung epithelial cell culture system provided as part of the company’s anti-COVID screening (ACS) platform to understand the molecular and pathological characteristics of the SARS-CoV-2 virus with a view to establishing a rational basis for testing potential drugs being developed at Purdue in vitro.